Concepedia

Kiyohiro Ando

KA

49

Publications

3.9K

Citations

29

H-Index

1992

Active since

Affiliations

Chiba Cancer Center(Current)

Showa University

The University of Tokyo

Hisamitsu Pharmaceutical (Japan)

Saitama Cancer Center

Kiyohiro Ando is an author at Chiba Cancer Center specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1992–2023

49

Publications

49

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.

Kiyohiro Ando, Takashi Moriyama, Luca G. Guidotti et al. · The Journal of Experimental Medicine · 1993 · 456 citations

, , +19

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

Luca G. Guidotti, Kiyohiro Ando, M V Hobbs et al. · Proceedings of the National Academy of Sciences · 1994 · 410 citations · Full text

, , +17

Activation of AMP-activated Protein Kinase Induces p53-dependent Apoptotic Cell Death in Response to Energetic Stress

Rintaro Okoshi, Toshinori Ozaki, Hideki Yamamoto et al. · Journal of Biological Chemistry · 2007 · 271 citations · Full text

Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation

Kiyohiro Ando, Toshinori Ozaki, Hideki Yamamoto et al. · Journal of Biological Chemistry · 2004 · 256 citations · Full text

, , +16

Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL

Kiyohiro Ando, Kazumasa Hiroishi, Takehisa Kaneko et al. · The Journal of Immunology · 1997 · 254 citations · Full text

Rows per page

1–5 of 49